Minerva Neurosciences Inc

NASDAQ:NERV   12:06:47 PM EDT
2.60
+0.02 (+0.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Minerva Neurosciences Inc Stock, NASDAQ:NERV

1601 Trapelo Road, Suite 286, Waltham, Massachusetts 02451
United States of America
Phone: +1.617.600.7373
Number of Employees: 11
http://www.minervaneurosciences.com

Description

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson�s disease. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Waltham, MA.